Belite Bio to Participate in Four Upcoming Investor Conferences
Summary
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio” or the 'Company”), a clinical-stage drug development company focu...
Description
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio” or the 'Company”), a clinical-stage drug development company focu...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source